Samsung Biologics Headquarters
Located in the heart of South Korea's global biocluster, Samsung Biologics' Headquarters features a sprawling campus of industry-leading facilities specializing in the development and manufacturing of biopharmaceutical products including ADCs. We offer a fully integrated service at a single site - a seamless solution that accelerates your discovery from early development through clinical and commercial manufacturing.


Bio Campus I 604 kL
- Plant 1
- 30,000 L
- Plant 2
- 154,000 L
- Plant 3
- 180,000 L
- Plant 4
- 240,000 L
Bio Campus II***720 kL
*** To be completed by 2032
ADC* Facility**
*ADC : Antibody-Drug Conjugate
**CGMP ready within 2024
Technologies & Features
-
- Accessibility
-
-
Full in-house capabilities at a single site
-
Multi-scale manufacturing
-
Real-time client access
-
-
- Efficiency
-
-
End-to-end offering
-
Simultaneous operation
-
Multiple operation modes
-
-
- Sustainability
-
-
Net Zero in our operations by 2050
-
Solar power generator
-
Reusable water treatment system
-
-
- Digitalization
-
-
Digitally optimized smart lab
-
Real-time data sharing
-
Enterprise Quality Unified
Information System (EQUIS)
-

ADC Platform Expanding multimodality capabilities
- Proven expertise with complex biologics manufacturing
- State-of-the-art facility and equipment with digitized systems
- Speed to market leveraging Samsung's excellence
New ADC facility to deliver client pipelines CGMP ready within 2024